Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - OPERATING EXPENSES
Operating Expenses HALO - Halozyme Therapeutics, Inc.
299 M
LAST VALUE
86.56%
2 YEAR CAGR
7.24%
5 YEAR CAGR
8.78%
10 YEAR CAGR